| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |